Solinas et al. [23] reported that CBD down-regulated the ERK and AKT signaling pathways in glioblastoma cells (U87-MG and T98G) in a dose-dependent manner and also decreased the hypoxia-inducible factor (HIF-1a) expression in U87-MG cells. This evidence concerns the gene AKT1 and glioblastoma.